These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7778055)

  • 21. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
    Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo.
    Trovati M; Anfossi G; Cavalot F; Massucco P; Mularoni E; Emanuelli G
    Diabetes; 1988 Jun; 37(6):780-6. PubMed ID: 2838353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical evaluation of platelet aggregation in whole human blood.
    Riess H; Braun G; Brehm G; Hiller E
    Am J Clin Pathol; 1986 Jan; 85(1):50-6. PubMed ID: 3079628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of endothelin-1 on aggregation of normal and uremic platelets.
    Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
    Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of co-dergocrine on platelet aggregation.
    Santos RO; Rodrigues R
    Braz J Med Biol Res; 1990; 23(3-4):325-7. PubMed ID: 2094545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
    Alarayyed NA; Graham BR; Prichard BN; Smith CC
    Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M; Milani M; Picano T; Oliviero U; Russo N; Coto V
    Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Papaverine inhibits human platelet aggregation induced by ADP.
    Serro-Azul MI; Bydlowski SP; Chamone DA
    Braz J Med Biol Res; 1992; 25(5):521-8. PubMed ID: 1342229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet aggregation in whole blood by alcohol.
    Torres Duarte AP; Dong QS; Young J; Abi-Younes S; Myers AK
    Thromb Res; 1995 Apr; 78(2):107-15. PubMed ID: 7482428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
    Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.
    Li B; Huang R; Wang R; Liu Y; Stief CG; Hennenberg M
    Pharmacol Res Perspect; 2021 May; 9(3):e00771. PubMed ID: 33929093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor.
    Malini PL; Strocchi E; Zanardi M; Milani M; Ambrosioni E
    Lancet; 1997 Jul; 350(9070):15-8. PubMed ID: 9217714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of streptokinase, urokinase, and recombinant tissue plasminogen activator on platelet aggregability and stability of platelet aggregates.
    Terres W; Umnus S; Mathey DG; Bleifeld W
    Cardiovasc Res; 1990 Jun; 24(6):471-7. PubMed ID: 2167173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes.
    Ratti S; Quarato P; Casagrande C; Fumagalli R; Corsini A
    Eur J Pharmacol; 1998 Aug; 355(1):77-83. PubMed ID: 9754941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.